Pt Kalba Farma Tbk PTKFY

$13.57 -0.73 (-5.07%)

Valuation

Market cap
—
Revenue TTM
$0
Net income TTM
$0
PE ratio
—
Forward PE
—
Profit margin
0.00%
Debt to equity
—

Trading

Volume
100
Avg volume
722
Day's range
$13.57 – $13.57
Shares out
—
Stochastic %K
27%
Beta
—
Analysts
Strong Buy
Price target
—

Price

Company profile

PT Kalbe Farma Tbk., together with its subsidiaries, engages in the development, manufacture, and trading of pharmaceutical products in Indonesia. It operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; anima...

Show more

PT Kalbe Farma Tbk., together with its subsidiaries, engages in the development, manufacture, and trading of pharmaceutical products in Indonesia. It operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business, and E-health products. In addition, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. The company was incorporated in 1966 and is headquartered in Jakarta, Indonesia.

Industry
Drug Manufacturers - General
Sector
Healthcare
Phone
62 21 4287 3888
Website
https://www.kalbe.co.id
Address
Gedung KALBE, Jl. Let. Jend. Suprapto Kav. 4 Cempaka Putih, Jakarta, Indonesia

Latest news

No headlines yet.